FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/05/2025
Voltar para busca
Dado oficial do USPTO
ELASMOGEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ELASMOGEN
ST13
US500000079379490Classe
5, 42, 44
Pedido
79379490
Registro
7567642
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
25
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
19/04/2023
Data de registro
19/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/11/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
MICKLEBURGH, LINDA BOHANNON
Unidade examinadora
L60
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Elasmogen Ltd
Representantes
Charlene M. Krogh Dorsey & Whitney LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for treatment of cancerinflammatory diseasesauto-inflammatory diseasesautoimmune diseases and eye diseases and disorders; biological preparations for treatment of cancerinflammatory diseasesauto-inflammatory diseasesautoimmune diseases and eye diseases and disorders; diagnostic preparations agentssubstances for medical purposes; anti-angiogenesis preparations; anti-cancer preparations; anti-inflammatory preparations; pharmaceutical and biochemical preparations for the treatment or prevention of cancerinfectious diseasephysiological disordershormonal disordersinherited diseasesingle gene disordersrespiratory diseasesgastro-intestinal disorderscirculatory disordersdermatological conditionsimmuno-deficienciesorgan damagecell proliferationperipheral neurological disordersgenitourinary disordersmusculoskeletal disordersblood disorders; diagnostic reagents for medical use; DNAantibodies and proteins for medical diagnosis purposes; DNA and antibodies and proteins that stimulate cells for medical use; DNAantibodies and proteins for therapeutic use for treatment of cancerinflammatory diseasesauto-inflammatory diseasesautoimmune diseases and eye diseases and disorders; diagnostic preparations for medical purposes; reagents for medical use
Classe 42
Medical and pharmacological research services; scientific and technological servicesnamely scientific researchanalysis and testing in the field of cancerinflammatory diseasesauto-inflammatory diseasesautoimmune diseaseseye diseases and disordersintracellular delivery of pharmaceuticals and therapeutics; scientific research for medical purposes in the field of cancerinflammatory diseasesauto-inflammatory diseasesautoimmune diseaseseye diseases and disordersintracellular delivery of pharmaceuticals and therapeutics; pharmaceutical research and drug development services; pharmaceutical testing; research and development in the biotechnology field; research and development services in the field of antibodies; biotechnology research services; scientific research in the nature of conducting clinical trials for others; biological researchclinical research and medical research; providing scientific information about the results of clinical trials for pharmaceutical products; research services in the field of diagnostic preparations; scientific laboratory services; custom design and development of biochemical assays; scientific and medical research laboratory services; research and development of new products for others; scientific research and analysis in the field of drug discovery; new product development in the field of pharmaceuticals for others; scientific advisory servicesmedical advisory services related to pharmaceutical development and testing; scientific research consultancy in the field of cancer researchinflammatory disease researchauto-inflammatory disease researchautoimmune disease researcheye disease and disorder researchintracellular delivery research of pharmaceuticals and therapeutics; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; consulting services for others in the field of designplanningimplementation and project management of scientific research and clinical trials; providing scientific research information; technical advisory services relating to scientific and clinical research; provision of technical and scientific information and consultancy in relation to the aforesaid services.
Classe 44
Medical services; medical advisory services relating to the treatmentrelief and prevention of cancerinfectious diseasephysiological disordershormonal disordersinherited diseasesingle gene disordersrespiratory diseasesgastro-intestinal disorderscirculatory disordersdermatological conditionsimmuno-deficienciesorgan damagecell proliferationperipheral neurological disordersgenitourinary disordersmusculoskeletal disordersblood disorders; preparation and provision of medical reports to patients and medical professionals; preparation and provision of medical information in the form of reports on pharmaceuticalsadvanced therapy medicinal productstherapeutic antibodies to patients and medical professionals; consultancyadvice and information in the field of healthcarepharmaceuticals and advanced therapy medicinal products
Publicações
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/04/2025
FIMP
FINAL DISPOSITION PROCESSED
16/04/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/02/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
19/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/09/2024
PUBO
PUBLISHED FOR OPPOSITION
03/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/07/2024
RFNT
REFUSAL PROCESSED BY IB
19/02/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/02/2024
RFRR
REFUSAL PROCESSED BY MPU
01/02/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/01/2024
CNRT
NON-FINAL ACTION WRITTEN
17/01/2024
DOCK
ASSIGNED TO EXAMINER
17/01/2024
MAFR
APPLICATION FILING RECEIPT MAILED
03/10/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/09/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/09/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ELASMOGEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.